|
|
| Phases of Development | Preclinical | Phase I | Phase II | Phase III | Registration | Approved | Marketed |
|---|
| Cancer | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Cardiovascular | 0 | 0 | 0 | 1 | 0 | 0 | 1 | | Endocrine / Metabolic | 1 | 4 | 2 | 4 | 1 | 1 | 4 | | Hepatic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Inflammation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | Neurology | 0 | 1 | 2 | 0 | 0 | 0 | 0 | | Ophthalmic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | | Pulmonary | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Peroxisome proliferation activated receptor (PPAR) gamma